Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22Colonic Neoplasms 12Rectal Neoplasms 11Carcinoma, Hepatocellular 10Stomach Neoplasms 7Digestive System Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Neoplasm Metastasis 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cholangiocarcinoma 2Recurrence 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoadjuvant Therapy 1Liver Neoplasms 1Intestinal Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Advanced Colorectal Cancer 1

Interventions

Acupuncture Therapy 3Paclitaxel 2Dexamethasone 2Cryotherapy 2Bortezomib 2XELOX 1Taxoids 1Sodium Selenite 1Sodium Chloride 1Silymarin 1Saline Solution 1Low-Level Light Therapy 1Glutamine 1G(M1) Ganglioside 1Folfox protocol 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1Amplified Fragment Length Polymorphism Analysis 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Peripheral Nervous System Diseases × Folfox protocol × Clear all
NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Jiangsu Province Hospital of Traditional Chinese Medicine

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡